1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
EUFOREA/EPOS2020 statement on the clinical considerations for CRSwNP care
- Contribution to journal › Article
- 2023
-
Mark
Evaluating treatment response to mepolizumab in patients with severe CRSwNP*
- Contribution to journal › Article
- 2019
-
Mark
EUFOREA consensus on biologics for CRSwNP with or without asthma
- Contribution to journal › Scientific review